Webb1 sep. 2015 · The coronary slow flow phenomenon (CSFP), first proposed by Beltrame et al. as a distinct clinical entity, is a coronary microvasculature disorder angiographically … Webb16 nov. 2012 · Heart rate (HR) is a precisely regulated variable, which plays a critical role in health and disease. Elevated resting HR is a significant predictor of all-cause and cardiovascular mortality in the general population and patients with cardiovascular disease (CVD). β-blocking drugs exert negative effects on regional myocardial blood flow and …
Coronary Slow Flow Phenomenon and Risk for Sudden Cardiac …
Coronary slow-flow phenomenon (CSFP) is an angiographic phenomenon characterised by the slow passage of contrast in the absence of obstructive coronary artery disease. Treatment and prognosis are obscure. Here find an outline of management of CSFP within the perimeter of available evidence. Visa mer Coronary slow-flow phenomenon was identified as an exclusive clinical entity in 1972 (1) where the distal opacification of the coronary artery is delayed on angiography in the absence of significant coronary artery … Visa mer The exact pathogenesis of CSFP is still not clear and is probably multi factorial. Functional and morphological abnormalities in the microvasculature, endothelial dysfunction, raised inflammatory markers, … Visa mer Coronary slow-flow phenomenon usually has a benign long term outcome but may be associated with relapses. Occasional ventricular arrhythmias … Visa mer Treatment modalities for CSFP are not well established. The T -type calcium channel blocker mibefradil was evaluated and was found to improve both clinical as well as angiographic outcomes (7). However, due to its … Visa mer Webb16 okt. 2007 · The coronary slow flow phenomenon is an angiographic finding characterized by delayed distal vessel opacification in the absence of epicardial … lithium calcium grease
Incidence, Predictors, and Prognosis of Coronary Slow-Flow and …
WebbTürkmen M, Toprak C, Açar G, et al. Plasma factor XI and XII activity in patients with slow coronary flow. Blood Coagul Fibrinolysis. 2014. 15. Durakoğlugil ME, Kocaman SA, Çetin M, et al. Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study. Anadolu Kardiyol Derg. 2013;13(1):39 ... WebbCoronary slow flow: Prevalence and clinical correlations. Circ J 2012; 76: 936–942. 5. Cin VG, Pekdemir H, Camsar A, Ciçek D, Akkus MN, Parmaksýz T, et al. Diffuse intimal … WebbAs a result of these changes, complications of left ventricular hypertrophy include: Heart failure. Irregular heart rhythms, called arrhythmias. Too little oxygen to the heart, called ischemic heart disease. Sudden, unexpected … improv seattle wa